Ketorolac tromethamine

Orlandini, S., Fanali, S., Furlanetto, S., Marras, A. M., and Pinzauti, S. (2004). Micellar electrokinetic chromatography for the simultaneous determination of ketorolac tromethamine and its impurities - multivariate optimization and validation.. Chromatogr. A 1032, 253-263. 

KETOROLAC TROMETHAMINE The combined duration of ketorolac IV/IM and oral is not to exceed 5 days. Oral use is only indicated as continuation therapy to IV/IM. 

Ketorolac tromethamine Ketorolac is indicated for the short-term (up to 5 days) management of moderately severe acute pain that requires analgesia at the opioid level. It is not indicated for minor or chronic painful conditions. Increasing the dose beyond the label recommendations will not provide better efficacy but will result in increasing risk of developing serious adverse events. 

Acetic acid derivatives (including INDOLE derivatives) diclofenac potassium diclofenac sodium etodolac indomethacin ketorolac tromethamine sulindac tolmetin sodium... 

Oral 12.5 mg tablets 25, 50, 75 mg capsules 100, 150, 200 mg extended-release capsules Ketorolac tromethamine (generic, Toradol)... 

A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage. Am J Obstet Gynecol. 2003 189 1559-1562. 

Common Name Ketorolac tromethamine Ketorolac trometamol Trometamol keterolac... 

J. S. Fleitman, I. W. Partridge, and D. A. Neu, Thimerosal analysis in ketorolac tromethamine ophthalmic solutions comparing HPLC and colorimetric techniques, Drug Dev. Ind. Pharm., 17 519(1991). 

---